Lv65
1670 积分 2025-06-19 加入
Systematic review and model-based analysis to identify whether renal safety risks of URAT1 inhibitors are fully determined by uric acid-lowering efficacies
10天前
已完结
Development of APH003─a Highly Potent, Selective, and Orally Bioavailable IRAK4 PROTAC Degrader for the Treatment of Inflammatory Diseases
1个月前
已完结
Discovery of APH02174 as a Highly Selective and Orally Bioavailable IRAK4 Degrader for the Treatment of Inflammatory Diseases
1个月前
已完结
Discovery and Preclinical Evaluation of TPM003: A Novel GLP-1/GIP/Glucagon Triple Hormone Receptor Agonist with Robust Efficacy in Obesity and NASH
1个月前
已完结
Design and Evaluation of 3-Phenyloxetane Derivative Agonists of the Glucagon-Like Peptide-1 Receptor
1个月前
已完结
Discovery of an Orally Efficacious Positive Allosteric Modulator of the Glucagon-like Peptide-1 Receptor
1个月前
已完结
Discovery and Evaluation of DA-302168S as an Efficacious Oral Small-Molecule Glucagon-Like Peptide-1 Receptor Agonist
1个月前
已完结
Discovery of Selenium-Containing Derivatives as Potent and Orally Bioavailable GLP-1R Agonists
1个月前
已完结
Cellular and signalling mechanisms that regulate the blood–brain barrier
2个月前
已完结
Understanding the Blood-Brain Barrier: From Physiology to Pathology
2个月前
已完结